---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-23-056314"
form_type: "8-K"
ticker: "COYA"
cik: "0001835022"
company_name: "Coya Therapeutics, Inc."
filed_at: "2023-03-01T23:59:59+00:00"
generated_at: "2026-06-18T18:48:39.285229+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "high"
source: SEC EDGAR
---

# Coya Therapeutics grants stock options to CEO, President/CMO, and CFO/COO

## Summary
- CEO Howard Berman granted options to purchase 165,000 shares at $3.85 per share.
- President/CMO Adrian Hepner and CFO/COO David Snyder each granted options for 115,000 shares.
- Options vest in 36 equal monthly installments with full acceleration on change of control.
- Options expire 10 years from grant date; exercise price equals closing price on grant date.

## SEC filing metadata
- accession: 0001193125-23-056314
- form_type: 8-K
- ticker: COYA
- cik: 0001835022
- company_name: Coya Therapeutics, Inc.
- filed_at: 2023-03-01T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1835022/000119312523056314/0001193125-23-056314-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1835022/000119312523056314/d476471d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-23-056314
- JSON: https://secwatch.observer/filing/0001193125-23-056314.json
- Plain text: https://secwatch.observer/filing/0001193125-23-056314.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.